Random

FDA

Protect The Children FDA!

Healthy Skeptic new FDA

Protect The Children FDA!

Suzanne B. Robotti

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

Issues Related to Healthcare News FDA

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

FDA: Why Drugs Should Take A Long Time To Get To Market

FDA: Why Drugs Should Take A Long Time To Get To Market

Suzanne B. Robotti

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

Time For The FDA To Get Tough On Off-Label Drug Promotion

Time For The FDA To Get Tough On Off-Label Drug Promotion

FDA Reinforces Warnings About Kratom

News Wellness Articles FDA

FDA Reinforces Warnings About Kratom

Patient Advocacy Groups: Help or Hindrance to FDA Approval?

Patient Advocacy Groups: Help or Hindrance to FDA Approval?

FDA Approves Tresiba

FDA Approves Tresiba

Lamictal Interactions With Estrogen-Containing Drugs

FDA SIDE EFFECTS UPDATE: Lamictal Interactions With Estrogen-Containing Drugs, and More

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

Drug Recalls

Drug Recalls

Pressure Building on FDA For More Rigorous Sunscreen Testing

Pressure Building on FDA for More Rigorous Sunscreen Testing

Trump and the Undermining of the FDA

Trump and the Undermining of the FDA

FDA Drug Recalls and Warnings: Atorvastatin

FDA Drug Recalls and Warnings: Atorvastatin; Labeling Mix-Up with Muscle Relaxant Cyclobenzaprine, and More

FDA’s Black Box Warning for Xeljanz Leaves Patients, Doctors Scratching Their Heads

FDA’s Black Box Warning for Xeljanz Leaves Patients, Doctors Scratching Their Heads

FDA

FDA Yanks Approval of Cholesterol Drugs Over Lack of Benefit

Required Postmarketing Studies For New Drugs

Required Postmarketing Studies For New Drugs

Q&A: Dr. Robert Blankfield Challenges the FDA on Safety

Q&A: A Doctor Challenges the FDA on Safety

Scott Gottlieb’s FDA Legacy

Scott Gottlieb’s FDA Legacy

Transforming U.S. Drug Policy, equitable healthcare

MedShadow Articles

Opinion: Transforming U.S. Drug Policy for Better Drug Safety

Suzanne B. Robotti

Load More

x

x